Amyloid beta protein (25-35) stimulation of phospholipase C in LA-N-2 cells

被引:0
|
作者
Singh, IN
Sorrentino, G
Kanfer, JN
机构
[1] UNIV MANITOBA, DEPT BIOCHEM & MOL BIOL, WINNIPEG, MB R3E 0W3, CANADA
[2] UNIV NAPLES, FAC MED, IST SCI NEUROL, NAPLES, ITALY
关键词
Alzheimer's disease; amyloid beta protein; phospholipase C; receptor-mediated; inositol phosphates;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid beta protein (25-35) stimulated appearance of H-3-inosilol phosphates from [H-3] inositol-prelabeled LA-N-2 cells was investigated. This stimulation was unaltered by extra- and intracellular calcium chelators in a calcium-free medium or by several protein kinase inhibitors. This phospholipase C stimulation by amyloid beta protein appeared to be pertussis toxin sensitive. It is possible that this phospholipase C stimulation by amyloid beta protein is a receptor-mediated process. This possibility is based on two related observations. The stimulation is ablated by the presence of conventional antagonists for metabotropic, adrenergic, and bombesin agonists. The IC50 values were 12 mu M for propranolol, 15 mu M for AP-3, and 25 nM for [Tyr(4),D-Phe(12)] bombesin. Additional support comes from results of densensitization and resensitization experiments. Amyloid beta protein stimulation of phospholipase C was absent from LA-N-2 cells previously treated with norepinephrine, trans-1-amino-1,3-cyclopentanedicarboxylic acid (t-ACPD), bombesin, or amyloid beta peptide. In a similar manner, LA-N-2 cells previously treated with amyloid beta protein were no longer responsive to norepinephrine, t-ACPD, or bombesin. The responsiveness to amyloid beta protein returned, subsequent to a period of resensitization for the individual agonists. It is suggested that this observed amyloid beta protein stimulation of phospholipase C may be responsible for the elevated quantity of inositol seen in the brains of Alzheimer's disease patients.
引用
收藏
页码:252 / 258
页数:7
相关论文
共 50 条
  • [41] beta-amyloid peptide secretion by a microglial cell line is induced by beta-amyloid-(25-35) and lipopolysaccharide
    Bitting, L
    Naidu, A
    Cordell, B
    Murphy, GM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (27) : 16084 - 16089
  • [42] β-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons
    Cazzaniga, Emanuela
    Bulbarelli, Alessandra
    Cassetti, Arianna
    Lonati, Elena
    Re, Francesca
    Palestini, Paola
    Mutoh, Tatsuro
    Masserini, Massimo
    JOURNAL OF NEUROSCIENCE RESEARCH, 2007, 85 (10) : 2253 - 2261
  • [43] Free radical generation and lipid peroxidation by beta amyloid 25-35 peptide in PC12 cells
    Hayashi, Y
    Ueda, Y
    Yokoyama, H
    Nakajima, A
    Mitsuyama, Y
    Ohya-Nishiguchi, H
    Kamada, H
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 246A - 246A
  • [44] Cytotoxicity of beta-amyloid peptide 25-35 on vascular smooth muscle cells and attenuation by vitamin E
    Gwebu, ET
    Williams, J
    Mathis, D
    Warden, JA
    Selassie, M
    Richardson, S
    Gwebu, NT
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 1997, 33 (09) : 672 - 673
  • [45] INTRACEREBRAL BETA-AMYLOID(25-35) PRODUCES TISSUE-DAMAGE - IS IT NEUROTOXIC
    RUSH, DK
    ASCHMIES, S
    MERRIMAN, MC
    NEUROBIOLOGY OF AGING, 1992, 13 (05) : 591 - 594
  • [46] Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro
    Cuevas, Elvis
    Rosas-Hernandez, Hector
    Burks, Susan M.
    Ramirez-Lee, Manuel A.
    Guzman, Aida
    Imam, Syed Z.
    Ali, Syed F.
    Sarkar, Sumit
    METABOLIC BRAIN DISEASE, 2019, 34 (05) : 1365 - 1374
  • [47] Effect of beta-Amyloid Peptide Fragment 25-35 on Nonselective Permeability of Mitochondria
    E. F. Shevtzova
    E. G. Kireeva
    S. O. Bachurin
    Bulletin of Experimental Biology and Medicine, 2001, 132 : 1173 - 1176
  • [48] BETA-AMYLOID (25-35) FORMS CONGO RED POSITIVE AGGREGATES INVITRO
    LEE, JM
    LORENS, SA
    GUJRATI, M
    THOMAS, C
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (03): : 307 - 307
  • [49] Chemical degradation of beta-amyloid [25-35] peptide under physiological conditions
    Jost, K
    Varga, J
    Szabo, Z
    Penke, B
    Zarandi, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (04) : 141 - 141
  • [50] Role of glycolysis and antioxidant enzymes in the toxicity of amyloid beta peptide Aβ25-35 to erythrocytes
    Kosenko, E. A.
    Solomadin, I. N.
    Marov, N. V.
    Venediktova, N. I.
    Poghosyan, A. S.
    Kaminsky, Yu. G.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2008, 34 (05) : 586 - 592